SCHEMBL23045236

SCHEMBL23045236

NC(=O)OCCNCCOC(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.46
CHRM2 P08172 2/20 0.46
CHRM4 P08173 2/20 0.46
CHRM5 P08912 2/20 0.46
CHRM1 P11229 2/20 0.46
CHRM3 P20309 2/20 0.46
CHRNB2 P17787 2/20 0.46
CHRNA4 P43681 2/20 0.46
HTR1A P08908 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
CHRNA7 P36544 1/20 0.46
ALOX15 P16050 1/20 0.43
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CD274 Q9NZQ7 2/20 0.35
PDCD1LG2 Q9BQ51 1/20 0.35
SCN1A P35498 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN3A Q9NY46 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18116052 0.91 LMNA (0.41) LMNACHRM2CHRM4CHRM5CHRM1
SCHEMBL14445313 0.91 TSHR (0.40) LMNACHRM2CHRM4CHRM5CHRM1
SCHEMBL1246711 0.91 CA12 (0.46) LMNACHRM2CHRM4CHRM5CHRM1
SCHEMBL20094988 0.89 ALOX15 (0.46) LMNACHRM2CHRM4CHRM5CHRM1
SCHEMBL23045228 0.87 LMNA (0.42) LMNACHRM2CHRM4CHRM5CHRM1
SCHEMBL28980314 0.87 CHRM2 (0.38) LMNACHRM2CHRM4CHRM5CHRM1
SCHEMBL5250838 0.85
SCHEMBL5247574 0.85 ACHE (0.47) LMNACHRM2CHRM4CHRM5CHRM1
SCHEMBL28995266 0.83 CYP2C19 (0.47) LMNACHRM2CHRM4CHRM5CHRM1
SCHEMBL6960579 0.83 CHRNB2 (0.47) LMNACHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107660202-B Water-soluble prodrugs 大日本住友制药肿瘤公司 2021-12-24 CN disclosed
WO-2021039616-A1 COMBINATION THERAPY AND BIOMARKER INDICATING EFFICACY THEREOF 大日本住友製薬株式会社 2021-03-04 WO disclosed